Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects
Cancer Nexus · 2026-04 · 2 (2)
DOI: 10.1002/cnx2.70021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Nexus, online erschienen am 17.02.2026. Verfasst von Yu Han und 5 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 406 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review provides a mechanistic overview of recent advances in LNP engineering for RNA therapeutics. We systematically analyze how key physicochemical parameters and structural elements, including ionizable lipid headgroups, linkers, tail architectures, helper lipids, cholesterol analogs, and surface modifications, govern biodistribution, endosomal escape, immunogenicity, and therapeutic efficacy. Emerging targeting paradigms, encompassing ligand‐mediated active targeting, formulation‐driven intrinsic targeting, and administration‐route optimization, are discussed with a focus on tumor and immune organ delivery. In addition, we highlight enabling methodologies such as DNA barcoding, multiplexed in vivo screening, and data‐driven lipid design that are reshaping LNP discovery. Finally, translational challenges and future directions for precision RNA delivery in cancer therapy are discussed, with an emphasis on how rational LNP design can be leveraged to overcome cancer‐specific barriers such as tumor heterogeneity, stromal constraints, and the immunosuppressive tumor microenvironment (TME).
Zitieren
APA
Han, Y., Wang, Y., Gao, X., Lei, Y., Li, Y., & Tang, Z. (2026). Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects. Cancer Nexus, 2(2). https://doi.org/10.1002/cnx2.70021
Vancouver
Han Y, Wang Y, Gao X, Lei Y, Li Y, Tang Z. Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects. Cancer Nexus. 2026;2(2). doi:10.1002/cnx2.70021
BibTeX
@article{Han2026,
author = {Han, Yu and Wang, Ying and Gao, Xintao and Lei, Yan and Li, Yantao and Tang, Zhiyong},
title = {Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects},
journal = {Cancer Nexus},
year = {2026},
volume = {2},
number = {2},
doi = {10.1002/cnx2.70021}
}
EUVIMED